Skip Navigation

Cardiovascular Research 1997 34(1):179-184; doi:10.1016/S0008-6363(97)00016-3
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Oltman, C. L
Right arrow Articles by Dellsperger, K. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oltman, C. L
Right arrow Articles by Dellsperger, K. C
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Effects of glycosylated hemoglobin on vascular responses in vitro

Christine L Oltman*, David D Gutterman, Eric C. Scott, Jennifer M Bocker and Kevin C Dellsperger

Department of Internal Medicine and the Cardiovascular Center, University of Iowa, Iowa City, IA and the Department of Veterans Affairs, Iowa City, IA, USA

* Corresponding author: 200 ML, Department of Internal Medicine, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA. Tel. +1 319 335-7633; Fax +1 319 353-6343; E-mail: coltman@blue.weeg.uiowa.edu

Vascular responses to endothelium-dependent vasodilators are greatly impaired in vivo, while isolated blood vessels from animals with diabetes mellitus demonstrate less consistent degrees of impairment. Glycation of proteins, such as hemoglobin, has been implicated in the vascular abnormalities associated with diabetes. Objective: The purpose of this study was to test the hypothesis that glycosylated hemoglobin is capable of reducing endothelium-dependent vasodilator responses, possibly explaining impaired dilation observed in vivo. Methods: To test this hypothesis, the effect of glycosylated hemoglobin (GH) on vascular responses was studied in several vascular beds, including ventricular microvessels and coronary, mesenteric, femoral, and renal arteries. Coronary arterioles were isolated and mounted between two glass pipettes in a pressurized (30 cmH2O) organ chamber. Isolated artery segments were studied using a standard isometric ring technique. Results: In ventricular microvessels, 10 nM nGH (non-GH) and GH both attenuated the relaxation to Ach. A lower concentration, 1 nM nGH or GH, did not alter dilation to Ach. In coronary, femoral, mesenteric and renal artery segments, endothelium-dependent responses were not altered by the presence of 10 or 100 nM nGH or GH. Conclusion: In coronary microvessels, and coronary, femoral, mesenteric and renal arteries, GH is not responsible for the impaired endothelial function associated with diabetes mellitus.

KEYWORDS Glycosylated hemoglobin; Diabetes; Coronary vasculature; Microcirculation; Acetylcholine; Dog, arteries


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. L. Oltman, L. L. Richou, E. P. Davidson, L. J. Coppey, D. D. Lund, and M. A. Yorek
Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1780 - H1787.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Lakhani, W. Yang, A. Dooley, E. El-Mahdi, M. Sundaresan, S. McLellan, R. Bruckdorfer, A. Leonard, A. Seifalian, and P. Hardiman
Aortic function is compromised in a rat model of polycystic ovary syndrome
Hum. Reprod., March 1, 2006; 21(3): 651 - 656.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Zhang, C. L. Oltman, T. Lu, H.-C. Lee, K. C. Dellsperger, and M. VanRollins
EET homologs potently dilate coronary microvessels and activate BKCa channels
Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2430 - H2440.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. H. Zink, C. L. Oltman, T. Lu, P. V. G. Katakam, T. L. Kaduce, H.-C. Lee, K. C. Dellsperger, A. A. Spector, P. R. Myers, and N. L. Weintraub
12-Lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H693 - H704.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. L. Oltman, N. L. Kane, D. D. Gutterman, R. S. Bar, and K. C. Dellsperger
Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size
Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E176 - E181.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. L. Oltman, N. L. Weintraub, M. VanRollins, and K. C. Dellsperger
Epoxyeicosatrienoic Acids and Dihydroxyeicosatrienoic Acids Are Potent Vasodilators in the Canine Coronary Microcirculation
Circ. Res., November 2, 1998; 83(9): 932 - 939.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. M. Pieper
Review of Alterations in Endothelial Nitric Oxide Production in Diabetes : Protective Role of Arginine on Endothelial Dysfunction
Hypertension, May 1, 1998; 31(5): 1047 - 1060.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.